Fund Holdings — Commodore Capital LP

Total Portfolio Value
$2.05B
Total Bought
$464.55M
Total Sold
$152.61M
Net Transaction
+$311.94M
Filing Period:
Securities
▲▼
SharesValue ($K)
Q2 2025
▲▼
Q3 2025
▲▼
Change
▲▼
Q2 2025
▲▼
Q3 2025
▲▼
Weight (%)
▲▼
Change
▲▼
MERUS N V3,525,0003,525,0000185,415331,87916.20%+146,464
COGENT BIOSCIENCES INC(COGT)2,311,1647,250,000+4,938,83616,594104,1105.08%+87,516
AMYLYX PHARMACEUTICALS INC(AMLX)04,075,478+4,075,478055,3862.70%+55,386
TERNS PHARMACEUTICALS INC05,700,000+5,700,000042,8072.09%+42,807
RELAY THERAPEUTICS INC(RLAY)13,350,00017,000,000+3,650,00046,19188,7404.33%+42,549
SOLENO THERAPEUTICS INC610,0001,350,000+740,00051,10691,2604.46%+40,154
PHARVARIS N V
COM
1,911,4332,418,476+507,04333,64160,3412.95%+26,700
CENTESSA PHARMACEUTICALS PLC3,298,2892,850,000-448,28943,34069,1133.37%+25,773
ASSEMBLY BIOSCIENCES INC01,000,000+1,000,000025,6001.25%+25,600
LB PHARMACEUTICALS INC(LBRX)01,500,000+1,500,000023,6851.16%+23,685
ALKERMES PLC(ALKS)2,450,0003,096,754+646,75470,09592,9034.54%+22,808
ORUKA THERAPEUTICS INC(ORKA)1,419,7141,753,054+333,34015,91533,7111.65%+17,796
TYRA BIOSCIENCES INC(TYRA)3,100,0003,375,000+275,00029,66747,2162.30%+17,549
BRIGHT MINDS BIOSCIENCES INC(DRUG)500,000500,000013,05530,3301.48%+17,275
AGIOS PHARMACEUTICALS INC(AGIO)2,325,0002,338,287+13,28777,33093,8594.58%+16,529
NUVALENT INC1,375,0001,400,000+25,000104,913121,0725.91%+16,160
XENON PHARMACEUTICALS INC(XENE)3,025,0002,700,000-325,00094,683108,4055.29%+13,723
PEPGEN INC(PEPG)02,357,319+2,357,319010,8910.53%+10,891
KYMERA THERAPEUTICS INC(KYMR)750,000750,000032,73042,4502.07%+9,720
ENANTA PHARMACEUTICALS INC(ENTA)0800,000+800,00009,5760.47%+9,576
SAB BIOTHERAPEUTICS INC(SABS)04,401,500+4,401,50008,8470.43%+8,847
PROTAGONIST THERAPEUTICS INC1,075,0001,025,000-50,00059,41568,0913.32%+8,676
CELLDEX THERAPEUTICS INC NEW(CLDX)3,450,0003,028,335-421,66570,20878,3433.82%+8,136
CYTOMX THERAPEUTICS INC(CTMX)7,692,3007,692,300017,46224,5381.20%+7,077
MIND MEDICINE MINDMED INC5,000,0003,225,000-1,775,00032,45038,0231.86%+5,573
TANGO THERAPEUTICS INC(TNGX)1,500,0001,500,00007,68012,6000.62%+4,920
AVALO THERAPEUTICS INC(AVTX)483,000483,00002,4106,1390.30%+3,729
SPYRE THERAPEUTICS INC(SYRE)1,988,0841,988,084029,76233,3201.63%+3,559
VISTAGEN THERAPEUTICS INC(VTGN)1,575,0001,575,00003,1505,5910.27%+2,441
ENLIVEN THERAPEUTICS INC4,692,8094,692,809094,13896,0624.69%+1,924
VIRIDIAN THERAPEUTICS INC(VRDN)4,875,0003,200,000-1,675,00068,15369,0563.37%+904
PERCEPTIVE CAP SOLUTIONS COR
CL A ORD SHS
750,000750,00007,9657,9200.39%-45
APOGEE THERAPEUTICS INC(APGE)290,000290,000012,59511,5220.56%-1,073
CIDARA THERAPEUTICS INC1,175,000585,000-590,00057,23456,0202.73%-1,215
INHIBIKASE THERAPEUTICS INC(IKT)5,397,4885,397,488010,5258,7440.43%-1,781
CRESCENT BIOPHARMA INC.(CBIO)453,686450,829-2,8577,3225,3600.26%-1,962
NEUROGENE INC(NGNE)427,8660-427,8666,3970—-6,397
NURIX THERAPEUTICS INC(NRIX)3,948,6533,780,055-168,59844,97534,9281.71%-10,047
VERA THERAPEUTICS INC(VERA)800,0000-800,00018,8480—-18,848
SCHOLAR ROCK HLDG CORP(SRRK)1,450,0000-1,450,00051,3590—-51,359
Page 1 of 1
Commodore Capital LP — 13F Holdings — Q3 2025 | TickerTrail